[Progress towards the varicella vaccination in China]

Area of Science:

• Public Health
• Vaccinology
• Epidemiology

Background:

• The varicella vaccine was licensed in China in 1997 but is not yet part of the national immunization program.
• Several provinces and municipalities have adopted regional immunization schedules for varicella.
• Accumulating evidence on vaccine safety and effectiveness in China necessitates a comprehensive review.

Purpose of the Study:

• To summarize the progress of varicella vaccination in China.
• To provide an evidence-based reference for guiding immunization practices.
• To review available vaccines, schedules, safety, efficacy, coverage, impact, and policies.

Main Methods:

• Literature review of varicella vaccination in China.
• Synthesis of data on vaccine characteristics, safety, and efficacy.
• Analysis of immunization policies and coverage rates.

Main Results:

• Varicella vaccine licensed in 1997, with regional but not national program inclusion.
• Growing body of evidence on vaccine safety and effectiveness.
• Data on vaccine coverage, impact, and policy integration presented.

Conclusions:

• A comprehensive review of varicella vaccination progress in China is needed.
• Evidence supports guiding varicella immunization practices with updated data.
• National policy integration remains a key consideration for broader vaccine impact.